Daptomycin for Children in Clinical Practice Experience

Silvia Garazzino, Elio Castagnola, Maria Di Gangi, Rita Ortolano, Andrzej Krzysztofiak, Agostino Nocerino, Susanna Esposito, Patrizia D’Argenio, Luisa Galli, Giuseppe Losurdo, Carmelina Calitri, Pier Angelo Tovo, Roberto Bandettini, Salvatore Giordano, Piera Dones, Ottavio Ziino, Clara Mosa, Margherita Robazza, Claudia Tagliabue, Laura LancellaFrancesca Carraro

Research output: Contribution to journalArticle

Abstract

Data on daptomycin use in the pediatric setting are scanty. We conducted a multicenter, retrospective study on 46 children treated with intravenous daptomycin at a mean dosage of 7.0 mg/kg/day and for a median of 14 days. Three children had adverse events possibly related to daptomycin. The drug was overall well tolerated, even with prolonged treatment.

Original languageEnglish
JournalPediatric Infectious Disease Journal
DOIs
Publication statusAccepted/In press - Feb 23 2016

    Fingerprint

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Infectious Diseases
  • Microbiology (medical)

Cite this

Garazzino, S., Castagnola, E., Di Gangi, M., Ortolano, R., Krzysztofiak, A., Nocerino, A., Esposito, S., D’Argenio, P., Galli, L., Losurdo, G., Calitri, C., Tovo, P. A., Bandettini, R., Giordano, S., Dones, P., Ziino, O., Mosa, C., Robazza, M., Tagliabue, C., ... Carraro, F. (Accepted/In press). Daptomycin for Children in Clinical Practice Experience. Pediatric Infectious Disease Journal. https://doi.org/10.1097/INF.0000000000001121